T0	Interventions 38 61	receptor-γ pioglitazone
T1	Interventions 485 506	(PPAR-γ) pioglitazone
T2	Interventions 815 921	trial of 45 mg daily pioglitazone versus placebo, with a 3-month duration/arm and a 2-month washout period
T3	Interventions 1448 1471	treatment, pioglitazone
T4	Interventions 1613 1625	with placebo
T5	Interventions 1627 1648	Further, pioglitazone
T6	Interventions 1799 1823	Addition of pioglitazone